Skip to main content

Table 4 Correlations of semiquantitative high/intermediate TILs/“TIL score” with clinicopathological parameters in stage IIIC/IVB endometrioid-type endometrial carcinoma (n = 47)

From: Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages

Parameter

Total

Number of cases (%)

High/Intermediate

CD3+

P

CD8+

P

CD3+

P

CD8+

P

“TIL score”

P

E-TILs

E-TILs

S-TILs

S-TILs

(4 to 8)

Age

  ≤ 50

8

3

(28)

0.46

3

(28)

0.70

3

(28)

0.43

3

(28)

1.00

2

(25)

0.69

  > 50

39

21

(54)

20

(51)

23

(59)

17

(44)

14

(36)

Stage

 IIIC

37

20

(53)

0.49

21

(57)

0.072

21

(57)

0.73

18

(49)

0.15

14

(38)

0.45

 IVB

10

4

(40)

2

(20)

5

(50)

2

(20)

2

(20)

Histological grade

 G1

12

5

(42)

0.67

5

(42)

0.83

7

(58)

0.94

4

(33)

0.38

2

(17)

0.28

 G2

16

8

(50)

8

(50)

9

(56)

9

(56)

7

(44)

 G3

19

11

(53)

10

(53)

10

(53)

7

(37)

7

(37)

Lymphovascular invasion

 Positive

41

20

(49)

0.66

19

(46)

0.41

21

(51)

0.20

16

(39)

0.37

13

(32)

0.39

 Negative

6

4

(67)

4

(67)

5

(83)

4

(67)

3

(50)

Lymph node metastasis

 Positive

42

22

(52)

0.66

21

(50)

1.00

24

(57)

0.64

19

(45)

0.37

14

(33)

1.00

 Negative

5

2

(40)

2

(40)

2

(40)

1

(20)

2

(40)

MMR protein

 Deficient

18

9

(50)

1.00

8

(44)

0.76

10

(56)

1.00

8

(44)

1.00

5

(28)

0.54

 Proficient

29

15

(52)

15

(52)

16

(55)

12

(41)

11

(38)

Total

47

24

  

23

  

26

  

20

  

16

  
  1. P values were calculated by chi-squared test or Fisher exact test
  2. E-TILs Epithelial tumor-infiltrating lymphocytes, MMR Mismatch repair, S-TILs Stromal tumor-infiltrating lymphocytes